InvestorsHub Logo
Followers 30
Posts 1475
Boards Moderated 0
Alias Born 07/10/2013

Re: Bartsdad post# 36093

Tuesday, 02/16/2021 10:28:49 PM

Tuesday, February 16, 2021 10:28:49 PM

Post# of 44690
BARTSDAD Nath said he was surprised to find almost all of the patients had abnormalities in the brain.

He said bright spots visible on their brain scans represented areas of inflammation. Dark spots represented bleeding in the brain, which Nath said was likely a result of blood vessels leaking.

https://kstp.com/coronavirus/new-study-shows-some-covid-19-patients-end-up-with-damage-to-brains-february-15-2021/6014166/

CAN VIP HELP??? Neurodegenerative disorders (NDDs) are characterized by neuronal death in the brain. The mechanism of the neuronal death is too complicated to be fully understood, although in many NDDs, aging and neurotoxins are known risk factors. In the central and peripheral nervous system, vasoactive intestinal peptide (VIP), a 28-amino acid neuropeptide, is released to support neuronal survival in both physiological and pathological condition. VIP can inhibit the neurodegeneration induced by the loss of neurons. The indirect protection effect is mainly mediated by glial cells through the production of neurotrophic factor(s) and inhibition of proinflammatory mediators. By remolding the structure and improving the transfer efficiency of VIP, its nerve protective function could be further improved. Its neuroprotective action and efficacy in inhibiting a broad range of inflammatory responses make VIP or related peptides becoming a novel therapeutic method to NDDs. In this review, we aim to summarize the relationship between VIP and NDDs.

https://www.researchgate.net/publication/309491952_The_effects_of_vasoactive_intestinal_peptide_in_neurodegenerative_disorders